F
Franziska Schwarz
Researcher at Charité
Publications - 9
Citations - 339
Franziska Schwarz is an academic researcher from Charité. The author has contributed to research in topics: Type 2 Diabetes Mellitus & Diabetes mellitus. The author has an hindex of 7, co-authored 9 publications receiving 298 citations. Previous affiliations of Franziska Schwarz include Federal Institute for Risk Assessment.
Papers
More filters
Journal ArticleDOI
Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
Thomas Bobbert,Franziska Schwarz,Antje Fischer-Rosinsky,Andreas Pfeiffer,Matthias Möhlig,Knut Mai,Joachim Spranger +6 more
TL;DR: FGF- 21 is an independent predictor of the metabolic syndrome and T2DM in apparently healthy Caucasians, and results may indicate FGF-21 resistance precedes the onset of the metabolism syndrome and type 2 diabetes mellitus.
Journal ArticleDOI
Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness.
Thomas Bobbert,Jens Raila,Franziska Schwarz,Knut Mai,Andrea Henze,Andreas Pfeiffer,Florian J. Schweigert,Joachim Spranger +7 more
TL;DR: The data support that the transport complex of vitamin A is associated with the IMT, an established parameter of atherosclerosis.
Journal ArticleDOI
Relation between fibroblast growth factor–21, adiposity, metabolism, and weight reduction
Knut Mai,Franziska Schwarz,Thomas Bobbert,J. Andres,Anke Assmann,Andreas Pfeiffer,Joachim Spranger +6 more
TL;DR: It is confirmed that FGF-21 levels are associated with markers of lipid metabolism and an estimate of abdominal adiposity, and the finding that moderate weight loss did not induce changes of FGF -21 levels in humans suggests that F GF-21 is not directly regulated by fat mass under those conditions.
Journal ArticleDOI
Chemerin and prediction of Diabetes mellitus type 2.
Thomas Bobbert,Franziska Schwarz,Antje Fischer-Rosinsky,Lukas Maurer,Matthias Möhlig,Andreas Pfeiffer,Knut Mai,Joachim Spranger +7 more
TL;DR: The aim of this study was to analyse whether chemerin predicts type 2 diabetes mellitus, and to investigate the role of adipokine Chemerin in this development.
Journal ArticleDOI
Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2
Franziska Schwarz,Zehra Karadeniz,Antje Fischer-Rosinsky,Diana M. Willmes,Joachim Spranger,Andreas L. Birkenfeld,Andreas L. Birkenfeld,Andreas L. Birkenfeld +7 more
TL;DR: Reducing the expression of Indy/CeNAC2 increases life span in C. elegans, an effect mediated at least in part by AMPK/aak2.